scispace - formally typeset
Open AccessJournal ArticleDOI

Privileged Scaffolds for Library Design and Drug Discovery

TLDR
This review explores the concept of using privileged scaffolds to identify biologically active compounds through building chemical libraries by revealing through four selected examples the present state of the art in privileged scaffold library synthesis.
About
This article is published in Current Opinion in Chemical Biology.The article was published on 2010-06-01 and is currently open access. It has received 1160 citations till now.

read more

Citations
More filters
Journal ArticleDOI

Pharmacological inhibition of cystine–glutamate exchange induces endoplasmic reticulum stress and ferroptosis

TL;DR: Dixon, Patel, et al. as mentioned in this paper found that erastin is a very effective inhibitor of system xc− function and that it is over 1000 times more potent than the previously known best inhibitor, sulfasalazine.
Journal ArticleDOI

Single-electron transmetalation in organoboron cross-coupling by photoredox/nickel dual catalysis

TL;DR: A mechanistically distinct single-electron transfer-based strategy for the activation of organoboron reagents toward transmetalation that exhibits complementary reactivity patterns.
Journal ArticleDOI

Chalcone: A Privileged Structure in Medicinal Chemistry.

TL;DR: This review aims to highlight the recent evidence of chalcone as a privileged scaffold in medicinal chemistry and is expected to be a comprehensive, authoritative, and critical review of the chal cone template to the chemistry community.
Journal ArticleDOI

Deep reinforcement learning for de novo drug design

TL;DR: The ReLeaSE method is used to design chemical libraries with a bias toward structural complexity or toward compounds with maximal, minimal, or specific range of physical properties, such as melting point or hydrophobicity.
References
More filters
Journal ArticleDOI

The evolving role of natural products in drug discovery

TL;DR: Recent technological advances that help to address issues such as the lack of compatibility of traditional natural-product extract libraries with high-throughput screening and unrealized expectations from current lead-generation strategies have led to a renewed interest in natural products in drug discovery.
Journal ArticleDOI

Target-oriented and diversity-oriented organic synthesis in drug discovery.

TL;DR: Several synthetic planning principles for diversity-oriented synthesis and their role in the drug discovery process are presented in this review.
Journal ArticleDOI

Drugs for bad bugs: confronting the challenges of antibacterial discovery

TL;DR: The experience of evaluating more than 300 genes and 70 high-throughput screening campaigns over a period of 7 years is shared, and what is learned is looked at and how that has influenced GlaxoSmithKline's antibacterials strategy going forward.
Journal ArticleDOI

Methods for drug discovery: development of potent, selective, orally effective cholecystokinin antagonists

TL;DR: 3-(Acylamino)-5-phenyl-2H-1,4-benzodiazepines, antagonists of the peptide hormone cholecystokinin (CCK), are described, and the method of development of these compounds is discussed in terms of its relevance to the general problem of drug discovery.
Journal ArticleDOI

A Planning Strategy for Diversity‐Oriented Synthesis

TL;DR: Although the distinct goals of DOS do not permit the application of retrosynthetic concepts and thinking, these foundations are being built on, by using parallel logic, to develop a complementary procedure known as forward-Synthetic analysis, which facilitates synthetic planning, communication, and teaching in this evolving discipline.
Related Papers (5)